Reply: 'Comments on Stromal disrupting effects of nab-paclitaxel in pancreatic cancer'

Br J Cancer. 2014 Oct 14;111(8):1677-8. doi: 10.1038/bjc.2014.129. Epub 2014 Mar 18.

Authors

R Alvarez¹, M Musteanu², E Garcia-Garcia², P P Lopez-Casas², D Megias², C Guerra², M Muñoz², Y Quijano¹, A Cubillo¹, J Rodriguez-Pascual¹, C Plaza¹, E de Vicente¹, S Prados¹, S Tabernero¹, M Barbacid², F Lopez-Rios¹, M Hidalgo³

Affiliations

¹ Centro Integral Oncológico Clara Campal (CIOCC), Oña 10, 28050 Madrid, Spain.
² Spanish National Cancer Research Centre (CNIO), Melchor Fernández Almagro 3, 28029 Madrid, Spain.
³ 1] Centro Integral Oncológico Clara Campal (CIOCC), Oña 10, 28050 Madrid, Spain [2] Spanish National Cancer Research Centre (CNIO), Melchor Fernández Almagro 3, 28029 Madrid, Spain.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Adenocarcinoma / drug therapy*
Animals
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Female
Fibroblasts / pathology*
Humans
Male
Pancreatic Neoplasms / drug therapy*

Grants and funding

250297/ERC_/European Research Council/International